{"task_id": "510931e2a1b52324", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 301/464)", "text": "roids and others (lesion dependent)\nVasculitis\n291\n\n--- Page 313 ---\nApproach to Serologies\nINFLAMMATORY MARKERS\nERYTHROCYTE SEDIMENTATION RATE (ESR) (non\nspecific)\n\u0002\nDISORDERS\nelevated in vasculitis such as temporal\narteritis and polymyalgia rheumatica and almost all\ninflammatory disorders (rheumatologic, infectious,\nmalignancy), anemia, renal disease, pregnancy,\nbirth control pills, thyroid disease, and old age\n\u0002\nUTILITY\nassociated with disease activity in tem\nporal arteritis and polymyalgia rheumatica. Normal\nvalue corrected for age and is usually less than\n[age in years + 10 (if female)]/2\nC REACTIVE PROTEIN (CRP) (non specific)\n\u0002\nDISORDERS\nelevated in vasculitis such as temporal\narteritis and polymyalgia rheumatica and almost\nall inflammatory disorders(rheumatologic, infectious,\nmalignancy), obesity, diabetes, CAD, and smoking\n\u0002\nUTILITY\nassociated with disease activity in tem\nporal arteritis and polymyalgia rheumatica\nRHEUMATOID ARTHRITIS\nRHEUMATOID FACTOR\npolyclonal IgM against Fc\nportion of IgG (non specific)\n\u0002\nDISORDERS\nsignificantly elevated in rheumatoid\narthritis (sens 80%), Sjogren\u2019s syndrome, mixed\ncryoglobulinemia, and subacute bacterial endocar\nditis. Somewhat elevated in other rheumatologic\ndiseases (SLE, MCTD, polymyositis, sarcoidosis),\npulmonary and hepatic diseases, infections, and\nmalignancy. May also be positive in the normal\nelderly\n\u0002\nUTILITY\nseronegative rheumatoid arthritis does\nnot have extraarticular findings. Does not correlate\nwith disease activity\nANTICYCLIC CITRULLINATED PEPTIDES (CCP)\n(very specific)\n\u0002\nUTILITY\nvery useful for diagnosis of rheumatoid\narthritis (sens 85%, spc 95%). For patients with\nelevated rheumatoid factor of >50 U/mL and\nfulfilling other criteria, rheumatoid arthritis is diag\nnosed without need for anti CCP. However, if rheu\nmatoid factor <50 U/mL, consider anti CCP testing\n(suggests rheumatoid arthritis if positive)\nLUPUS\nANTINUCLEAR ANTIBODIES (ANA) (non specific\nbut most sensitive test for SLE)\n\u0002\nDISORDERS\nSLE (sens >99%), mixed connective\ntissue disease (sens >95%), Sjogren\u2019s syndrome\n(sens\n75%),\ninflammatory\nmyopathies\n(sens\n>75%), scleroderma (sens >60 90%), rheumatoid\narthritis (sens 15 35%), and normal elderly\nLUPUS (CONT\u2019D)\n\u0002\nSTAINING PATTERNS\n\u0002\nRIM\nmost specific, SLE\n\u0002\nHOMOGENOUS\nSLE\n\u0002\nNUCLEOLAR\nscleroderma, CREST\n\u0002\nDIFFUSE\nnon specific\n\u0002\nSPECKLED\nmost common, least specific, con\nsider SLE, MCTD, scleroderma, Sjogren\u2019s\n\u0002\nUTILITY\nnegative ANA can help to exclude SLE,\nbut ANA testing is not useful in known SLE patients\nANTI DOUBLE STRANDED DNA (most specific test\nfor SLE)\n\u0002\nDISORDERS\nelevated in SLE (sens 20 30%, spc\n>95%) and chronic active hepatitis. Usually not\nelevated in drug induced lupus\n\u0002\nUTILITY\nassociated with lupus nephritis and disease\nactivity in SLE (most useful for following disease)\nANTI SMITH (very specific)\n\u0002\nDISORDERS\nSLE. Usually not elevated in drug\ninduced lupus\n\u0002\nUTILITY\nSLE (sens 30%, spc >95%). Associated\nwith lupus nephritis\nANTI RNP\n\u0002\nDISORDERS\nSLE, mixed connective tissue disease\n\u0002\nUTILITY\nassociated with milder SLE\nANTI HISTONE\n\u0002\nDISORDERS\ndrug induced lupus (sens >90%, very\nspc), SLE (sens >50%)\nC3, C4\n\u0002\nDISORDERS\ndecreased in SLE, cryoglobulinemic\nvasculitis, Henoch Schonlein purpura\n\u0002\nUTILITY\nassociated with lupus nephritis and dis\nease\nactivity\nin\nSLE\nand\ncryoglobulinemic\nvasculitis\nSCLERODERMA\nANTI SCL 70 (TOPOISOMERASE I) (very specific)\n\u0002\nDISORDERS\nscleroderma (sens 20 30%, very spc)\n\u0002\nUTILITY\nassociated with disease activity\nANTICENTROMERE\n\u0002\nDISORDERS\nCREST (sens 90%), idiopathic Raynaud\u2019s\n(sens 25%)\nSJOGREN\u2019S SYNDROME\nANTI RO (SS A)\n\u0002\nDISORDERS\nSjogren\u2019s syndrome (sens 75%), SLE\n(sens 25%)\n\u0002\nUTILITY\nassociated with sicca in other connective\ntissue disorders, extraglandular disease in Sjog\nren\u2019s syndrome, heart block in neonates with\nanti Ro positive mothers, cutaneous lupus rash,\nphotosensitivity, and thrombocytopenia in SLE\n292\nApproach to Serologies", "text_length": 3918, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 301/464)", "type": "chunk", "chunk_index": 300, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.659810", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.660811", "status": "complete", "chunks_added": 3}